Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C275129-200 200 µl (0.5 mg/ml) $952 
Antibody

Polyclonal Rabbit anti‑Human ACE2 / ACE‑2 Antibody (APC, aa140‑172, IHC, WB) LS‑C275129

Polyclonal Rabbit anti‑Human ACE2 / ACE‑2 Antibody (APC, aa140‑172, IHC, WB) LS‑C275129

Antibody:
ACE2 / ACE-2 Rabbit anti-Human Polyclonal (aa140-172) (APC) Antibody
Application:
IHC, WB, ELISA
Reactivity:
Human
Format:
Allophycocyanin, Unmodified
Other formats:
Price
Catalog Number
$952
LS-C275129-200
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
ACE2 / ACE-2 Rabbit anti-Human Polyclonal (aa140-172) (APC) Antibody
Application:
IHC, WB, ELISA
Reactivity:
Human
Format:
Allophycocyanin, Unmodified
Other formats:

Specifications

Description
ACE-2 antibody LS-C275129 is an APC-conjugated rabbit polyclonal antibody to human ACE-2 (ACE2) (aa140-172). Validated for ELISA, IHC and WB. Cited in 2 publications.
Target
Human ACE2 / ACE-2
Synonyms
ACE2 | ACE-related carboxypeptidase | ACEH | Metalloprotease MPROT15 | SARS-CoV2 Coronavirus Receptor | SARS-CoV-2 Coronavirus Receptor | COVID-19 viral receptor
Host
Rabbit
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG Polyclonal
Conjugations
Allophycocyanin. Also available Unconjugated or conjugated with Biotin, FITC, HRP, PE.
Purification
Affinity purified
Modifications
Unmodified
Epitope
aa140-172
Specificity
This ACE2 (SARS Receptor) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 140-172 amino acids from the Central region of human ACE2 (SARS Receptor).
Applications
  • IHC
  • Western blot
  • ELISA
  • Applications tested for the base form of this product only
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
PBS, pH 7.2, No preservatives added
Storage
Store product at 4°C in the dark. DO NOT FREEZE. Stable at 4°C for 1 year after receipt as an undiluted liquid. APC conjugates are sensitive to light.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About ACE2 / ACE-2
Q9BYF1 NM_021804 NP_068576.1

LSBio Ratings

ACE2 / ACE-2 Antibody (aa140-172, APC) for IHC, WB/Western, ELISA LS-C275129 has an LSBio Rating of
Publications (4.1)

Publications (2)

Defining the Immune Responses for SARS-CoV-2-Human Macrophage Interactions. bioRxiv : the preprint server for biology. 2021 Jul;

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions. Mai M Abdelmoaty, Pravin Yeapuri, Jatin Machhi, Katherine E Olson, Farah Shahjin, Vikas Kumar, You Zhou, Jingjing Liang, Kabita Pandey, Arpan Acharya, Siddappa N Byrareddy, R Lee Mosley, Howard E Gendelman. Frontiers in immunology. 2021 October;12:741502.

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/25/2024